Colgate-Palmolive Company $CL Shares Acquired by Lombard Odier Asset Management Switzerland SA

Lombard Odier Asset Management Switzerland SA lifted its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 211.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 131,671 shares of the company’s stock after buying an additional 89,409 shares during the period. Lombard Odier Asset Management Switzerland SA’s holdings in Colgate-Palmolive were worth $10,405,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of CL. Norges Bank purchased a new stake in Colgate-Palmolive during the fourth quarter valued at about $861,670,000. Northwestern Mutual Wealth Management Co. lifted its stake in Colgate-Palmolive by 8,040.1% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 4,655,987 shares of the company’s stock valued at $380,666,000 after buying an additional 4,598,789 shares in the last quarter. Deutsche Bank AG lifted its stake in Colgate-Palmolive by 33.9% during the fourth quarter. Deutsche Bank AG now owns 10,845,857 shares of the company’s stock valued at $857,040,000 after buying an additional 2,746,920 shares in the last quarter. Franklin Resources Inc. lifted its holdings in shares of Colgate-Palmolive by 47.4% in the fourth quarter. Franklin Resources Inc. now owns 6,044,168 shares of the company’s stock valued at $477,610,000 after purchasing an additional 1,942,946 shares in the last quarter. Finally, Amundi lifted its holdings in shares of Colgate-Palmolive by 41.6% in the third quarter. Amundi now owns 6,294,445 shares of the company’s stock valued at $487,505,000 after purchasing an additional 1,850,412 shares in the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.

Colgate-Palmolive Price Performance

Shares of CL opened at $90.56 on Wednesday. The firm has a market cap of $72.47 billion, a PE ratio of 35.24, a PEG ratio of 4.78 and a beta of 0.33. The firm’s 50 day moving average price is $87.07 and its 200 day moving average price is $86.45. The company has a debt-to-equity ratio of 16.33, a quick ratio of 0.67 and a current ratio of 1.02. Colgate-Palmolive Company has a twelve month low of $74.54 and a twelve month high of $99.33.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, May 1st. The company reported $0.97 earnings per share for the quarter, beating the consensus estimate of $0.94 by $0.03. The firm had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.22 billion. Colgate-Palmolive had a net margin of 10.04% and a return on equity of 386.76%. The company’s revenue for the quarter was up 8.4% on a year-over-year basis. During the same quarter last year, the firm earned $0.91 earnings per share. As a group, research analysts expect that Colgate-Palmolive Company will post 3.81 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Monday, July 20th will be issued a dividend of $0.53 per share. This represents a $2.12 annualized dividend and a yield of 2.3%. The ex-dividend date is Monday, July 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is 82.49%.

Analyst Upgrades and Downgrades

CL has been the subject of a number of research analyst reports. TD Cowen restated a “hold” rating and issued a $85.00 target price on shares of Colgate-Palmolive in a report on Tuesday, March 31st. The Goldman Sachs Group restated a “buy” rating on shares of Colgate-Palmolive in a report on Friday, May 1st. UBS Group increased their target price on Colgate-Palmolive from $98.00 to $100.00 and gave the company a “buy” rating in a report on Monday, May 4th. Rothschild & Co Redburn set a $100.00 price target on shares of Colgate-Palmolive and gave the stock a “buy” rating in a research report on Tuesday, April 21st. Finally, Sanford C. Bernstein started coverage on shares of Colgate-Palmolive in a research report on Thursday, June 11th. They issued a “market perform” rating and a $96.00 price target for the company. Twelve analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to MarketBeat, Colgate-Palmolive has a consensus rating of “Moderate Buy” and a consensus price target of $95.88.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.